Chemical Composition and Biological Activity of Vietnamese Vernonia amygdalina Essential Oil: In Vitro and In Silico Studies
Article Sidebar
Views | PDF/EPUB Downloads:
127
/ 78
/ 15
Main Article Content
Abstract
Vernonia amygdalina Del. (Asteraceae) is widely used to treat intestinal diseases, abdominal pain, helminth infections, dysentery, gastritis, and pinkeye. However, the chemical composition and biological properties of the essential oil of V. amygdalina collected in Dak Lak, Vietnam, have not been investigated. Gas chromatography-mass spectrometry (GC-MS) was used to identify the chemical composition of V. amygdalina essential oil. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay and the agar disc diffusion method were used to evaluate the antioxidant and antibacterial activities of the essential oil, respectively. The binding energy between essential oil major constituents and Escherichia coli DNA gyrase subunit B (GyrB) was studied by molecular docking. The essential oil content was 0.67% by weight, and 40 constituents were identified, the major ones being 4-methylheptane (3.19%), 2-fluoromesitylene (26.61%), 4-(1,1-dimethylethyl) benzenethiol (10.99%), butylated hydroxytoluene (16.22%), 3-ethyl-4-heptanone (6.73%), and 3,5-dihydroxy-N,N-diethylbenzamide (13.91%). The strong antioxidant and antibacterial effects of V. amygdalina essential oil were demonstrated with an IC50 value of 6.4 ± 0.2 μg/mL and a lowest minimum inhibitory concentration (MIC) value of 4.6 ± 0.3 mg/mL, respectively. In molecular docking studies, the binding energy between the essential oil's major constituents and GyrB ranges from -6.0 to -4.5 kcal/mol. All major constituents were classified as “Caution” using the DL-AOT prediction server. Our results indicate that the essential oil of V. amygdalina collected in Dak Lak, Vietnam, has great potential in the pharmaceutical industry.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Akinpelu DA. Antimicrobial activity of Vernonia amygdalina leaves. Fitoterapia. 1999; 70(4):432-434.
Abosi AO, Raseroka BH. In vivo antimalarial activity of Vernonia amygdalina. Br J Biomed Sci. 2003; 60(2):89-91.
Trang NTT, Tin PV, Tuyet TT, Minh NCB, Nhu NQ, Quang NT. The antioxidant activities and the detoxify liver of Vernonia amygdalina Del. extract collected in Da Nang City. Can Tho J Med Pharm. 2024; 7:75-81.
Erasto P, Grierson DS, Afolayan AJ. Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. J Ethnopharmacol. 2006; 106(1):117-120.
Rachmaini F, Abdillah R, Anshari H, Juwita DA. Sub-acute toxicity study of bitter leaf (Vernonia amygdalina Del.) aqueous fraction on haematological parameters. Trop J Nat Prod Res. 2024; 8(3):6519-6524.
Do TL. Vietnamese medicinal plants and herbs. Hanoi: Medical Publishing House; 2006. 1294 p.
Adebodun GO, Dikne A, Egbeke A, Arikawe H, Bello B, Ekwobi K, Ogunsola AO. Ameliorative potentials of Vernonia amygdalina in high-fat diet and letrozole-induced polycystic ovary syndrome in female Wistar rats. Trop J Nat Prod Res. 2024; 8(4):6995-6999.
Halimatushadyah E, Sailah I, Tallei TE, Tamala Y, Safitri L, Humaedi A. In vitro and in silico study of antioxidants and anti-inflammatory activity of bitter leaves (Vernonia amygdalina Del.) extract. Trop J Nat Prod Res. 2025; 9(2):534-540.
Van CP, Van HN, Quang MB, Thanh ND, Van DN, Thanh TD, Minh NT, Thu HNT, Quang TN, Do TT, Thanh LP, Thu HDT, Tuan AHL. Stigmastane-type steroid saponins from the leaves of Vernonia amygdalina and their α-glucosidase and xanthine oxidase inhibitory activities. Nat Prod Res. 2024; 38(4):601-606.
Nerdy N, Margata L, Meliala L, Purba JS, Sembiring BM, Ginting S, Bakri TK. In silico evaluation of the physicochemical, pharmacokinetics, and toxicity profiles of sesquiterpene lactones of South African leaf (Vernonia amygdalina Delile). Trop J Nat Prod Res. 2021; 5(10):1835-1840.
Dao DTK. Study on extraction and determination of chemical composition in some extracts of Vernonia amygdalina stems in Cao Bang. Dissertation, The University of Danang; 2016. 129 p.
Hieu DT, Hanh NTH, Hong NTM, Huyen NTT. Morphological, anatomical characteristics and photochemicals of Bitter leaf harvested in Thai Nguyen. TNU J Sci Technol. 2016; 225(01):150-154.
Asawalam EF, Hassanali A. Constituents of the essential oil of Vernonia amygdalina as maize weevil protectans. Trop Subtrop Agroecosyst. 2006; 6(2):95-102.
Sonibare OO, Sonibare MA, Adesanya EO. Essential oil composition of Vernonia amygdalina Del. from Southwestern Nigeria. J Essent Oil-Bear Plants. 2009;12(1):185-188.
Ogunbinu AO, Flamini G, Cioni PL, Ogunwande IA, Okeniyi SO. Essential oil constituents of Eclipta prostrata (L.) L. and Vernonia amygdalina Delile. Nat Prod Commun. 2009; 4(3):421-424.
Erasto P, Grierson DS, Afolayan AJ. Evaluation of antioxidant activity and the fatty acid profile of the leaves of Vernonia amygdalina growing in South Africa. Food Chem. 2007; 104(2):636-642.
Georgewill OA, Georgewill UO. Evaluation of the anti-inflammatory activity of extract of Vernonia amygdalina. Asian Pac J Trop Med. 2010; 3(2):150-151.
Hanh DTB, Ngu TN, Bao PHT, Nguyen NPD, Trong PV, Loan LTT, Lam DT, Nguyen PH, Khuyen PTH, Truong PCH, Tran MH, Giap VD, To DC. Chemical composition and biological activities of essential oil from Plectranthus amboinicus collected in Dak Lak, Vietnam. Trop J Nat Prod Res. 2023; 7(11):5203-5210.
Khan K, Uddin R. Integrated bioinformatics based subtractive genomics approach to decipher the therapeutic function of hypothetical proteins from Salmonella typhi XDR H-58 strain. Biotechnol Lett. 2022; 44(2):279-298.
Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods. 2000; 44(1):235-249.
Bakchi B, Krishna AD, Sreecharan E, Ganesh VBJ, Niharika M, Maharshi S, Puttagunta SB, Sigalapalli DK, Bhandare RR, Shaik AB. An overview on applications of SwissADME web tool in the design and development of anticancer, antitubercular and antimicrobial agents: A medicinal chemist's perspective. J Mol Struct. 2022; 1259:132712.
Mukherjee A, Su A, Rajan K. Deep learning model for identifying critical structural motifs in potential endocrine disruptors. J Chem Inf Model. 2021; 61(5):2187-2197.
Jagannathan R. Characterization of drug-like chemical space for cytotoxic marine metabolites using multivariate methods. ACS Omega. 2019; 4(3):5402-5411.
Karlina N, Kunaedi A, Ahidin D, Jannah U, Zahiyah Y. Antioxidant activity test of African leaves purification extract (Vernonia amygdalina Del) with DPPH method. J Pharm Sci Community. 2023; 9(1):1-10.
Rumengan IFM, Rumampuk ND, Mandey LC, Kandou GD, Luntungan AH. Antioxidant activitiy of bitter leaves (Vernonia amygdalina) extract coated with the nanochitosan derived from parrot fish (Scarus sp) scales. IOP Conf Ser Earth Environ Sci. 2020; 517(1):012017.
Nhan NV, Linh NTN. Antibacterial activity of Vernonia amygdalina leaf extract on Bacillus cereus and Escherichia coli. J Anim Husb Sci Tech. 2021; 271:81-85.
Olusola‑Makinde O, Olabanji OB, Ibisanmi TA. Evaluation of the bioactive compounds of Vernonia amygdalina Delile extracts and their antibacterial potentials on water‑related bacteria. Bull Natl Res Cent. 2021; 45(1):191.
Ali M, Diso SU, Waiya SA, Abdallah MS. Phytochemical screening and antibacterial activity of Bitter leaf (Vernonia amygdalina). Ann Microbiol Infect Dis. 2019; 2(4):01-07.